Technical Description
The invention presents a potent ulcer treatment using rabeprazole-sodium combined with barium bioactive glass (BaBG) for enhanced drug effectiveness and sustained release.
Problems Addressed
- Adverse Effects of Conventional Treatment
- High Drug Dose
- High Manufacturing Time
- Costly Treatment
- High Infection Risk
- Nutritional Deficiencies Because of Conventional Treatment
Tech Features
- Diverse Formulation Ingredients
- Improved Drug Efficiency
- Improved Relative Bioavailability
- Sustained Release Effect
- Rabeprazole-sodium loaded onto Barium Bioactive glass
Target Audience
- Pharmaceutical Industry
- Biomedical Industries
- Chemical Industry
- Materials Science Companies
Tech ID: P27-1137 TRL 4 Patent Status: Granted Available For Exclusive and Non-exclusive License
